Late Breaking News

New Methadone Regulations

The comment period is now over. CSAT has formed a committee to review the comments and the regulations. A short meeting is planned for January 31, 2000. Two NAMA officers are on the committee Lisa Torres, Esq. and Joycelyn Woods.

Buprenorphrine Committee

A federal committee has been formed to review the guidelines for buprenorphrine prescribing. Joycelyn Woods will be the consumer representative on the committee. The first meeting is scheduled in February.

Patient’s Bill of Rights

NAMA has been asked to be a Steakholder in a group that will develop documents about Patient’s Rights.

Texas State Methadone Regulations

NAMA has been asked to be a Steakholder and to review the Texas Methadone Regulations.

Vermont

New England NAMA is very close to making methadone a reality in Vermont and New Hampshire. Contact Alice Diorio as to how you can help in this last push.

Similar Posts

  • Membership Application

    Admin 11/15/2021

    Send To: National Alliance of Methadone Advocates Inc.                                                                                                     Back To NAMA Home Page NAMA Membership Office 435 Second Avenue New York, NY 11000 Membership Application Name:   _______________________________________________________  Organization:  ________________________________________________________________________ Title:  ________________________________________________________ Degree(s):__________________________ Address:  ________________________________________________________________________ Address:  ________________________________________________________________________ City:   _____________________________________    State:   ______Postal Code:   ________Country:   ___ Home Phone: (___)__________________________   Work Phone:   (___)______________________    Alternate Phone:(___)________________________Fax:   (___)______________________________       Email:______________________________________ If you have email may we send you…

  • Directory Affiliates and Chapters

    Admin 02/12/2023

    NAMA Board of Directors Zachary Talbott, MSW, CMA President [email protected] Sharon Larson, RN, MS, CMA Vice Pressident [email protected] Brenda Davis, MSW, CASAC-T, CMA Treasurer [email protected] Megan Marx-Varela, MPA Secretary [email protected] Joycelyn Sue Woods, MA, CARC, CMA Executive Director [email protected] Paul Bowman, CMA, CARC [email protected] Sara E. Gefvert, CRS/CPS, CMA Technology and Communications [email protected] Walter Ginter, CMA Recovery and Peer Services [email protected] Charles Hilger, MSW, LDAC [email protected] Claude Hopkins,…

  • Next Training

    Admin 01/14/2022

    Training Schedule Certified MAT Advocate Training at the AATOD 2021 Conference . When: Saturday, April 10, 2021 Starts: 9 AM Where: The AATOD Conference will be virtual (Webinar) Register and Pay (Note: Regisration and Payment is through the Georgia Board.) Go Here Download Materials Training Materials For information about the conference visit the AATOD Conference…

  • DRAFT

    Admin 06/23/2022

    Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…

  • Discharge From Treatment for Drug Use

    Admin 02/25/2022

    Policy Statement Number 3 May 1994 It must be emphasized that methadone maintenance treatment is a medical treatment for narcotic addiction. Recent research has found that abstinent former heroin users have irregularities within their immune and endocrine systems. However, these irregularities are normalized with methadone maintenance. This further underscores that methadone maintenance is a medical…